AI-driven virtual screening uncovers two potent CDK9 inhibitors with anticancer effects in lab tests
A new and important discovery comes from the field of oncological research thanks to the joint work of researchers from the Sbarro Institute in Philadelphia, the National Cancer Institute—Pascale ...
The earliest stage of drug discovery is governed by a simple constraint: there are far more possible drug-like molecules than any pharmaceutical laboratory could ever test. A new deep learning system, ...
Machine learning doesn't replace human intelligence, but it can outlast human endurance, which makes it a helpful tool for ...
Colonoscopy quality indicators for colorectal cancer precursors: Sessile serrated lesion and adenoma detection rates from a large clinical study of a blood-based test for CRC screening. This is an ...
“It’s like a paradigm shift approach… to drive discovery”: a new machine-learning model predicts how molecules will influence gene expression and has been used to pick out promising drug candidates ...
Machine learning doesn't replace human intelligence, but it can outlast human endurance, which makes it a very helpful tool ...
Nathanael Hwang discusses how EHR-based machine learning models are adding value to patients with obstructive sleep apnea. Current screening approaches, such as the widely used STOP-BANG questionnaire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results